VEGFA and neoplasm: MDSCs also harbour tumor-promoting functions by non-immunological mechanisms, such as the promotion of angiogenesis (via VEGF and angiopoietins production) and matrix remodelling (via MMP9 expression), thus enabling cancer cells to move from the primary tumor to metastatic sites [61].